Kazem Javanmardi

Kazem Javanmardi


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2021 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
AHAva Soltani Hekmat
Ava Soltani Hekmat
ACAmeneh Chenari
Ameneh Chenari
HAHiva Alipanah
Hiva Alipanah
KJKazem Javanmardi
Kazem Javanmardi
Background: This study aimed to evaluate the protective effects of alamandine, a new member of the angiotensin family, against doxorubicin (DOX)-induced nephrotoxicity in rats. Methods: Rats were intraperitoneally injected with DOX (3.750 mg/kg/week) to reach a total cumulative dose of 15 mg/kg by day 35. Alamandine (50 µg/kg/day) was administered to the rats via mini-osmotic pumps for 42 days. At the end of the experiment, rats were placed in the metabolic cages for 24 h so that their water intake and urine output could be measured. After scarification, the rats’ serum and kidney tissues were collected, and biochemical, histopathological, and immunohistochemical studies were carried out. Results: DOX administration yielded increases in pro-inflammatory cytokines, including interleukin (IL)-1β and IL-6, pro-fibrotic proteins transforming growth factor-β (TGF-β), pro-inflammatory transcription factor nuclear kappa B (NF-κB), kidney malondialdehyde (MDA), creatinine clearance, blood urea nitrogen (BUN), and water intake. On the other hand, the DOX-treated group exhibited decreased renal superoxide dismutase (SOD), renal glutathione peroxidase (GPx) activity, and urinary output. Alamandine co-therapy decreased these effects, as confirmed by histopathology and immunohistochemical analysis. Conclusions: The results suggest that alamandine can prevent nephrotoxicity induced by DOX‎ in rats.

11 April 2007 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
PHParisa Hasanein
Parisa Hasanein
MPMohsen Parviz
Mohsen Parviz
MKMansoor Keshavarz
Mansoor Keshavarz
KJKazem Javanmardi
Kazem Javanmardi

19 November 2008 in Brain Research
Verified
Journal Article
Closed access
PHParisa Hasanein
Parisa Hasanein
NMNaser Mirazi
Naser Mirazi
KJKazem Javanmardi
Kazem Javanmardi

1 May 2009 in Brain Research
Verified
Journal Article
Closed access
MAMohammad Allahtavakoli
Mohammad Allahtavakoli
RMRoohollah Moloudi
Roohollah Moloudi
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
ASAli Shamsizadeh
Ali Shamsizadeh
KJKazem Javanmardi
Kazem Javanmardi

1 April 2016 in Chinese Journal of Traumatology
Verified
Journal Article
Open access
SHSeyed taghi Heydari
Seyed taghi Heydari
MVMehrdad Vossoughi
Mehrdad Vossoughi
AAArmin Akbarzadeh
Armin Akbarzadeh
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
YSYaser Sarikhani
Yaser Sarikhani
RTReza Tabrizi
Reza Tabrizi
The aim of this present study is to investigate the prevalence of alcohol and substance abuse (ASA) and its relationship with other risky driving behaviors among motorcycle drivers. This is a cross sectional study which is performed at Shiraz city of Iran. Data from motorcycle drivers were collected using a standard questionnaire in eight major streets at different times of the day. The data includes consumption of alcohol and other substances two hours before driving and some of the risky behaviors during driving. A total of 414 drivers with a mean ± SD age of (27.0 ± 9.3) years participated in the study. Alcohol or substance consumptions two hours before driving was significantly associated with risky driving behaviors such as using mobile phone during driving, poor maneuvering, and driving over the speed limit (both p < 0.001). It was also associated with carelessness about safety such as driving with technical defects (p < 0.001) and not wearing a crash helmet (p = 0.008). Screening for alcohol and substance consumption among motorcycle drivers is an efficient way to identify drivers that are at a greater risk for road traffic accidents.